Beaton Management Co. Inc. Edwards Lifesciences Corp Transaction History

Beaton Management Co. Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $15,736 - $18,134	-200 Reduced 7.08%	2,625 $220,000
Q4 2020 Feb 17, 2021	SELL	$71.69 - $91.23 $12,545 - $15,965	-175 Reduced 5.83%	2,825 $258,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $172,620 - $230,850	3,000 New	3,000 $207,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $52,410 - $81,000	-1,000 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$61.55 - $75.43 $61,550 - $75,430	1,000 New	1,000 $220,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Beaton Management Co. Inc. with notifications on news.